Oct 1, 2019, 05:33 AM by Michael Croft

BOURNEMOUTH, UK - Oct 1, 2019 - Solentim, the global leader in cell line development (CLD) instrumentation, is delighted to announce that Dr Mark Truesdale will join the Company as the new Chief Marketing Officer, effective immediately

Oct 1, 2019, 05:20 AM by Michael Croft

GUILDFORD, UNITED KINGDOM - Oct 1, 2019 - Research published in Nature by the Korea Advanced Institute of Science (KAIST) found that lymphatic vessels in the scull involved in the clearance of cerebrospinal fluid often become compromised with age

Sep 30, 2019, 17:14 PM by Michael Croft

BARCELONA, SPAIN - Sep 30, 2019 - X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today announced positive results from the Phase 2a portion of its open-label Phase 1/2 clinical trial of mavorixafor (X4P-001) in combination with axitinib (Inlyta®) in patients with advanced clear cell renal cell carcinoma (ccRCC)

Sep 30, 2019, 09:54 AM by Michael Croft

PHILADELPHIA, PA, UNITED KINGDOM - Sep 30, 2019 - There are 7,000 recognized rare disease conditions that affect between 25 and 30 million people in the United States alone, and the vast majority are totally unknown in the community

Sep 29, 2019, 22:29 PM by Michael Croft

SHIRLEY, NY - Sep 30, 2019 - With a high reputation among academic and industrial enzyme companies, Creative Enzymes has recently added three newly-developed enzyme services to 2019 product catalog, for researchers working in the life science field

Sep 29, 2019, 22:24 PM by Michael Croft

LONG ISLAND CITY, NY, UNITED STATES - Sep 25, 2019 - The past decade has witnessed an upsurging demand for lab testing. Whether it's just a simple routine analysis of chemical and physical properties of compounds or specifying impurities, which is slightly more difficult, lab testing is necessary

Sep 29, 2019, 22:20 PM by Michael Croft

NEW YORK, NY, UNITED STATES - Sep 19, 2019 - As one of the world's leading peptide suppliers, the New York-based company Creative Peptides announced the release of peptide library and peptide array, providing powerful tools for scientists who are involved with protein–protein interaction research, drug R&D and many other possible applications associated with biochemicals and pharmaceuticals

Sep 29, 2019, 22:20 PM by Michael Croft

SHIRLEY, NY - Sep 30, 2019 - As an excellent supplier and manufacturer, Creative Enzymes has recently upgraded several enzymes related services, such as enzyme expression and purification services, and enzyme engineering services, for researchers working in the life science or research field

Sep 27, 2019, 04:46 AM by Michael Croft

SHIRLEY, NY - Sep 27, 2019 - As an excellent supplier and manufacturer, Creative Enzymes has recently upgraded several enzymes related services, such as enzyme expression and purification services, and enzyme engineering services, for researchers working in the life science or research field

Sep 26, 2019, 22:22 PM by Michael Croft

SHIRLY, NY - Sep 27, 2019 - With a high reputation among academic and industrial enzyme companies, Creative Enzymes has recently added three newly-developed enzyme services to 2019 product catalog, for researchers working in the life science field

Sep 26, 2019, 13:54 PM by Michael Croft

SAN JOSE, CA, UNITED STATES - Sep 26, 2019 - Stratio, Inc. launchedLinkSquare, a smart handheld spectrometer, attaining innovation in usability, cost and size, designed to simplify infrared spectroscopy and ready to help laboratories deliver lab results to the palm of your hand

Sep 26, 2019, 10:55 AM by Michael Croft

Sep 26, 2019, 04:30 AM by Michael Croft

RHYMNEY, UK - Sep 26, 2019 - Sharp, a part of UDG Healthcare and a leading provider of clinical supply services, has strengthened its leadership team with the appointment of Sascha Sonnenberg as global head of business development for Sharp Clinical Supply Services

Sep 25, 2019, 13:50 PM by Michael Croft

MOUNTAIN VIEW, CA, UNITED STATES - Sep 25, 2019 - Hammerspace Data-as-a-Service Protects and Secures Data Across the Hybrid Multi-CloudA single platform serves and manages file data across any infrastructure, on-prem and on the cloudHammerspace, a software company smashing the complexity of how data is served and managed across the hybrid multi-cloud and containers, today announced enterprise hybrid cloud services for protecting and securing data

Sep 25, 2019, 08:08 AM by Michael Croft

PRINCETON, NJ - Sep 25, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced that the US Food and Drug Administration (FDA) has renewed its legacy licenses for Synchrogenix’s electronic Common Technical Document (eCTD) review software, GlobalSubmit REVIEW™ and GlobalSubmit VALIDATE™ for another year

Sep 25, 2019, 07:15 AM by Michael Croft

Bio-IT World | Bio-IT World is accepting entries for the 2020 Innovative Practices Awards competition.

Sep 24, 2019, 09:54 AM by Michael Croft

MILPITAS, CA - Sep 23, 2019 - ASEPCO, specialist valve manufacturer for bioprocessing applications and part of the Watson-Marlow Fluid Technology Group, is pleased to announce the opening of its new site

Sep 24, 2019, 09:16 AM by Michael Croft

NPR.org | Labs are churning out more and more synthetic DNA for scientists who want to use it to reprogram cells. Some say the technology has outpaced government safety guidelines put in place a decade ago.

Sep 24, 2019, 08:55 AM by Michael Croft

BOSTON, MA, UNITED STATES - Sep 24, 2019 -  iVexSol, a newly formed viral vector manufacturing company, today announced $2.0 million in new convertible debt funding led by Casdin Capital, LLC and BioLife Solutions (NASDAQ:BLFS)

Sep 24, 2019, 08:10 AM by Michael Croft

ROYSTON, UK - Sep 24, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has joined UK Medicines Discovery Catapult’s Discovery Services Platform, partnering with other best-in-class service providers to help improve preclinical drug discovery success rates